Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jan;45(1):37-41.
doi: 10.1136/jcp.45.1.37.

Enzyme immunoassay for anti-treponemal IgG: screening or confirmatory test?

H Young  1 , A Moyes, A McMillan, J Patterson
Affiliations

Enzyme immunoassay for anti-treponemal IgG: screening or confirmatory test?

H Young et al. J Clin Pathol. 1992 Jan.

Abstract

Aims: To review the performance of the Venereal Diseases Research Laboratory (VDRL) test and the Treponema pallidum haemagglutination assay (TPHA) as a combined screen for syphilis to provide a baseline for assessing screening by anti-treponemal IGG EIA.

Methods: Between 1980 and 1987 all serum samples were screened by both VDRL and TPHA tests. The FTA-ABS test was also used in suspected early primary syphilis, or when one of the other tests was positive. A positive result in a screening test was confirmed by quantitative testing. From 1988 all specimens were screened with an enzyme immunoassay (Captia Syph G) as a single screening test.

Results: Of the 44 primary, 47 secondary, and 38 early latent cases of syphilis, the VDRL and TPHA detected 32 (73%) and 31 (71%) of the primary cases; the combination detected 37 (84%). All 85 cases of cases of secondary and early latent infection were reactive in the TPHA test, whereas the VDRL was reactive in only 68 (80%). EIA had a reported sensitivity of 82% for primary infection.

Conclusions: EIA can be used as a single screening test for detecting early syphilis because its results are comparable with those of the combined VDRL and TPHA tests. The conventional VDRL test should not be used as a single screening test.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. JAMA. 1964 Jul 13;189:87-90 - PubMed
    1. Br J Vener Dis. 1975 Aug;51(4):227-31 - PubMed
    1. Lancet. 1989 Jul 15;2(8655):166-7 - PubMed
    1. Med J Aust. 1989 Oct 2;151(7):368, 370, 372 - PubMed
    1. Dermatologica. 1989;179(3):113-7 - PubMed

LinkOut - more resources